| Serial Number | 98440102 |
| Word Mark | SELFJECT |
| Filing Date | Friday, March 8, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, October 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | An injection device pre-filled with pharmaceutical preparations for the treatment of auto-immune disorders. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 8, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, August 6, 2024 |
| First Use In Commerce Date | Tuesday, August 6, 2024 |
| Party Name | Mallinckrodt Pharmaceuticals Ireland Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Dublin D15TX2V IE |
| Event Date | Event Description |
| Friday, March 8, 2024 | NEW APPLICATION ENTERED |
| Friday, March 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 6, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Tuesday, August 6, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Tuesday, August 6, 2024 | USE AMENDMENT FILED |
| Friday, September 20, 2024 | ASSIGNED TO EXAMINER |
| Monday, October 7, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, October 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 15, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 15, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 7, 2024 | NON-FINAL ACTION WRITTEN |